Abstract
Overeating and associated obesity are major public health problems. In addition to its notable adverse health consequences, the behavior of overeating has significant neurobiological and psychological underpinnings. Current classification systems of mental disorders (DSM-IV and ICD-10) address this increasingly prevalent “disorder” in a limited and inconsistent manner. Several similarities between overeating and substance dependence have been documented with regards to phenomenology, shared neurobiology, and treatment. This has led to suggestions that a new category of “food addiction” be added to our psychiatric nosology and that this category be included with substance use disorders under a broad rubric of “addiction disorders”. In this article, we consider the rationale for this recommendation and evaluate its pros and cons. We summarize how the problem of overeating is addressed in our current classification systems and discuss DSM-5 approaches to the issue.
Keywords: Binge-eating, obesity, addiction, DSM, psychiatric classification, commonalities, nosological, psychoanalytic, impulse, syndrome, anorexia, gambling, bulimia, DISORDER
Current Pharmaceutical Design
Title: Should Overeating and Obesity be Classified as an Addictive Disorder in DSM-5?
Volume: 17 Issue: 12
Author(s): Claudia Moreno and Rajiv Tandon
Affiliation:
Keywords: Binge-eating, obesity, addiction, DSM, psychiatric classification, commonalities, nosological, psychoanalytic, impulse, syndrome, anorexia, gambling, bulimia, DISORDER
Abstract: Overeating and associated obesity are major public health problems. In addition to its notable adverse health consequences, the behavior of overeating has significant neurobiological and psychological underpinnings. Current classification systems of mental disorders (DSM-IV and ICD-10) address this increasingly prevalent “disorder” in a limited and inconsistent manner. Several similarities between overeating and substance dependence have been documented with regards to phenomenology, shared neurobiology, and treatment. This has led to suggestions that a new category of “food addiction” be added to our psychiatric nosology and that this category be included with substance use disorders under a broad rubric of “addiction disorders”. In this article, we consider the rationale for this recommendation and evaluate its pros and cons. We summarize how the problem of overeating is addressed in our current classification systems and discuss DSM-5 approaches to the issue.
Export Options
About this article
Cite this article as:
Moreno Claudia and Tandon Rajiv, Should Overeating and Obesity be Classified as an Addictive Disorder in DSM-5?, Current Pharmaceutical Design 2011; 17 (12) . https://dx.doi.org/10.2174/138161211795656701
DOI https://dx.doi.org/10.2174/138161211795656701 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cyclophilin A as a Target of Cisplatin Chemosensitizers
Current Cancer Drug Targets Fabrication, Characterization, In vitro Evaluation of Solid Lipid Nanoemulsion of Flunarizine dihydrochloride for Nasal Delivery
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Pregabalin Dependence: A Case Report
Current Drug Safety Positron Emitting Tracers in Pre-Clinical Drug Development
Current Radiopharmaceuticals Design and Evaluation of Transdermal Patches of Timolol Maleate
Current Drug Delivery Health Anxiety (Hypochondriasis): an Emotional Disorder in An Alternative Taxonomy
Current Psychiatry Reviews Advances in Therapies of Cerebellar Disorders: Immune-mediated Ataxias
CNS & Neurological Disorders - Drug Targets The Potent Inhibitory Effect of β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property on Anti-Cyclic Citrullinated Peptide Antibodies, Rheumatoid Factor and Anti-dsDNA Antibodies in Patients with Rheumatoid Arthritis
Current Drug Discovery Technologies A Preliminary X-Ray Study of a Refolded PTS EIIBfruc Protein from Escherichia coli
Protein & Peptide Letters Role and Pharmacogenomics of TNF-α in Asthma
Mini-Reviews in Medicinal Chemistry Atypical Antipsychotics: Pharmacokinetics, Therapeutic Drug Monitoring and Pharmacological Interactions
Current Medicinal Chemistry Characterization of Endogenous Neural Progenitor Cells after Experimental Ischemic Stroke
Current Neurovascular Research The Role of DNA Methylation in the Pathogenesis and Treatment of Cancer
Current Clinical Pharmacology Analysis of Adverse Events Related to 720 Cases of Neural Progenitor Cell Transplantation
CNS & Neurological Disorders - Drug Targets Cannabinoids and Neuroprotection in Motor-Related Disorders
CNS & Neurological Disorders - Drug Targets Cognitive Behavioral Approaches for Treating Suicidal Behavior in Adolescents
Current Psychiatry Reviews Microvascular Endothelial Dysfunction in Obesity and Hypertension
Current Pharmaceutical Design Targeting Transient Receptor Potential Channels in Cardiometabolic Diseases and Myocardial Ischemia Reperfusion Injury
Current Drug Targets PET Radioligands for the Vesicular Acetylcholine Transporter (VAChT)
Current Topics in Medicinal Chemistry Is the Therapeutic Potential of Stem Cells for Myocardial Regeneration Limited by Proarrhythmic Effects?
Current Cardiology Reviews